Scientists at deCODE genetics, a subsidiary of Amgen, reveal today in Nature Genetics associations between rare ...
Piper Sandler analyst David Amsellem reiterated a Buy rating on Amgen (AMGN – Research Report) today and set a price target of $329.00. The ...
Shares of Amgen Inc. AMGN shed 2.39% to $306.86 Tuesday, on what proved to be an all-around favorable trading session for the ...
2d
News Medical on MSNRare loss-of-function variants in HECTD2 and AKAP11 confer a risk of bipolar disorderBipolar disorder is characterized by extreme mood swings, bouts of mania or hypomania, and episodes of depression. It is a ...
Quantinuum may not be a household name yet, and it’s not even publicly traded, but it has quickly become one of the most ...
2d
News-Medical.Net on MSNResearch identifies pressure-sensing protein behind gut motilityAfter every meal, the intestines perform an action called peristalsis - moving food through their hollow interiors with coordinated contractions and relaxations of the smooth muscle.
Scientists at deCODE genetics, a subsidiary of Amgen, reveal today in Nature Genetics associations between rare loss-of-function variants in two genes and bipolar disorder. REYKJAVIK, Iceland ...
Amgen today is the biggest biotechnology company in the world, but its plush headquarters, global reach and tens of thousands of employees belie its humble origins. Founded in 1980 as Applied ...
Amgen is planning to push its olpasiran candidate for reducing lipoprotein(a) into phase 3 as quickly as possible as it tries to catch up with rival programmes at Novartis. The US biotech has just ...
3don MSN
The trial results are critical, as it brings Eli Lilly’s pill one step closer to becoming a new, needle-free alternative for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results